Analysed ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) News Sources
Arcturus Therapeutics Refocuses on Rare Disease mRNA Pipeline After COVID Vaccine Success at ROTH Conf
23-03-2026
marketbeat.com
Arcturus Therapeutics Teases 12-Week Phase 2 CF Study After Well-Tolerated Inhaled mRNA Dosing
12-03-2026
marketbeat.com
Arcturus Therapeutics Holdings Inc (ARCT) Q4 2025 Earnings Call Highlights: Navigating Revenue ...
04-03-2026
yahoo.com
What is the current price of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)?
The current price of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) is $8.36.
ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) absolute price change since previous trading day?
The absolute price change of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) since the previous trading day is $0.14.
ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) percentage price change since previous trading day?
The percentage price change of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) since the previous trading day is 1.7032%.
What is the most recent average sentiment score for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)?
The most recent average sentiment score for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)?
The most recent sentiment for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) is .
SEC-8K** Filing Available For ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.